Edesa Biotech is trading at $6.50 (+14.84%) following a sharp extended-hours bid despite a lack of company-specific news.
- The move appears driven by thin after-hours liquidity rather than fundamental catalysts, as no earnings releases or guidance updates were identified.
- Broader market volatility saw the Nasdaq Composite decline 1.98%, which can often amplify outsized price swings in small-cap names during extended trading sessions.